Growth Metrics

Vericel (VCEL) Current Assets (2010 - 2026)

Vericel recorded quarterly Current Assets of $244.1 million in Q1 2026, down 1.36% quarter-over-quarter from $247.4 million in Q4 2025, and up 23.49% year-over-year from $197.6 million in Q1 2025.

Vericel's Current Assets history runs 17 years deep, the most recent figure standing at $244.1 million for Q1 2026.

  • In Q1 2026, Current Assets rose 23.49% year-over-year to $244.1 million; the TTM figure through Mar 2026 stood at $244.1 million (up 23.49% YoY), while the FY2025 annual figure was $247.4 million, up 16.29% from the prior year.
  • Current Assets came in at $244.1 million for Q1 2026 at Vericel, down from $247.4 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $247.4 million in Q4 2025 to a low of $151.9 million in Q1 2022.
  • A 5-year average of $195.2 million and a median of $190.5 million in 2024 frame the typical range for Current Assets.
  • Across the five-year window, Current Assets climbed 2.31% in 2024 and advanced 23.49% in 2026, its largest moves.
  • Vericel's Current Assets stood at $186.9 million in 2022, then rose by 10.04% to $205.6 million in 2023, then increased by 3.48% to $212.8 million in 2024, then climbed by 16.29% to $247.4 million in 2025, then fell by 1.36% to $244.1 million in 2026.
  • According to Business Quant data, Current Assets over the past three periods registered $244.1 million, $247.4 million, and $222.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 10.37 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 37.31 Mn
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 1.25 Bn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - 73.04 Mn
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 3.59 Mn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 11.73 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 18.21 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 4.22 Bn
10 Vericel 1.69 Bn 1.55 Bn 49.27 Mn 244.06 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 244.06 Mn
Dec 31, 2025 247.44 Mn
Sep 30, 2025 221.97 Mn
Jun 30, 2025 204.58 Mn
Mar 31, 2025 197.64 Mn
Dec 31, 2024 212.78 Mn
Sep 30, 2024 190.52 Mn
Jun 30, 2024 197.39 Mn
Mar 31, 2024 189.72 Mn
Dec 31, 2023 205.63 Mn
Sep 30, 2023 186.21 Mn
Jun 30, 2023 182.87 Mn
Mar 31, 2023 177.55 Mn
Dec 31, 2022 186.87 Mn
Sep 30, 2022 166.38 Mn
Jun 30, 2022 155.09 Mn
Mar 31, 2022 151.88 Mn
Dec 31, 2021 158.46 Mn
Sep 30, 2021 144.95 Mn
Jun 30, 2021 138.52 Mn
Mar 31, 2021 127.21 Mn
Dec 31, 2020 123.56 Mn
Sep 30, 2020 125.38 Mn
Jun 30, 2020 115.76 Mn
Mar 31, 2020 116.54 Mn
Dec 31, 2019 111.66 Mn
Sep 30, 2019 104.72 Mn
Jun 30, 2019 94.05 Mn
Mar 31, 2019 109.60 Mn
Dec 31, 2018 112.78 Mn
Sep 30, 2018 119.26 Mn
Jun 30, 2018 117.52 Mn
Mar 31, 2018 48.20 Mn
Dec 31, 2017 50.51 Mn
Sep 30, 2017 36.31 Mn
Jun 30, 2017 33.04 Mn
Mar 31, 2017 36.95 Mn
Dec 31, 2016 44.72 Mn
Sep 30, 2016 21.10 Mn
Jun 30, 2016 22.31 Mn
Mar 31, 2016 25.82 Mn
Dec 31, 2015 27.34 Mn
Sep 30, 2015 28.52 Mn
Jun 30, 2015 33.55 Mn
Mar 31, 2015 37.92 Mn
Dec 31, 2014 41.49 Mn
Sep 30, 2014 44.72 Mn
Jun 30, 2014 14.11 Mn
Mar 31, 2014 9.24 Mn
Dec 31, 2013 8.48 Mn
Sep 30, 2013 11.36 Mn
Jun 30, 2013 4.73 Mn
Mar 31, 2013 9.53 Mn
Dec 31, 2012 13.99 Mn
Sep 30, 2012 21.46 Mn
Jun 30, 2012 29.13 Mn
Mar 31, 2012 37.20 Mn
Dec 31, 2011 6.18 Mn
Sep 30, 2011 12.58 Mn
Jun 30, 2011 19.05 Mn
Dec 31, 2010 31.70 Mn